InsidersTradesSigma
Total declarations
Companies
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Insider track record
CEODisclosed buys
2
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the full record of transactions filed by Sklawer Andrew D, Chief Executive Officer. Officer active across 3 companies, notably Brickell Biotech, Inc.. Cumulatively, 3 reports have been recorded. Split: 2 buys · 0 sell. Total volume traded: €20k. History available since 17 May 2021. The latest transaction was disclosed on 17 May 2021 (Acquisition). Regulator: SEC (Form 4). The full history is openly available.
Declarations3 total
55,000 sharesCommon StockSEC:0001628280-23-033916:0
15,375 shares@ US$0.8050.0% of flowCommon StockSEC:0001062993-21-004868
Canonical exit: 15 Aug 2021 (T+90)
15,375 shares@ US$0.8050.0% of flowCommon StockSEC:0001062993-21-004868:0
Canonical exit: 15 Aug 2021 (T+90)
3 of 3 declarations
About Sklawer Andrew D
Sklawer Andrew D is the COO and Secretary at Brickell Biotech, Inc. He oversees the company's operations and ensures compliance of processes. His role is essential for the effective management of the organization.
